{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T13:18:42Z","timestamp":1788095922914,"version":"build-2803163510"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T00:00:00Z","timestamp":1623369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Danish Huntington's disease association Research foundation"},{"DOI":"10.13039\/501100005111","name":"Rigshospitalet","doi-asserted-by":"publisher","award":["the research board at Rigshospitalet"],"award-info":[{"award-number":["the research board at Rigshospitalet"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010359","name":"L\u00e6ge S\u00f8ren Segel og Hustru Johanne Wiibroe Segels Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Huntington\u2019s disease (HD) is an inherited, progressive neurodegenerative disease that has no cure. Striatal atrophy and hypometabolism has been described in HD as far as 15 years before clinical onset and therefore structural and functional imaging biomarkers are the most applied biomarker modalities which call for these to be exact; however, most studies are not considering the partial volume effect and thereby tend to overestimate metabolic reductions, which may bias imaging outcome measures of interventions.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>Evaluation of partial volume effects in a cohort of premanifest HD gene-expansion carriers (HDGECs).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>21 HDGECs and 17 controls had a hybrid 2-[<jats:sup>18<\/jats:sup>F]FDG PET\/MRI scan performed. Volume measurements and striatal metabolism, both corrected and uncorrected for partial volume effect were correlated to an estimate of disease burden, the CAG age product scaled (CAP<jats:sub>S<\/jats:sub>).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>We found significantly reduced striatal metabolism in HDGECs, but not in striatal volume. There was a negative correlation between the CAP<jats:sub>S<\/jats:sub> and striatal metabolism, both corrected and uncorrected for the partial volume effect. The partial volume effect was largest in the smallest structures and increased the difference in metabolism between the HDGEC with high and low CAP<jats:sub>S<\/jats:sub> scores. Statistical parametric mapping confirmed the results.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>A hybrid 2-[<jats:sup>18<\/jats:sup>F]FDG PET\/MRI scan provides simultaneous information on structure and metabolism. Using this approach for the first time on HDGECs, we highlight the importance of partial volume effect correction in order not to underestimate the standardized uptake value and thereby the risk of overestimating the metabolic effect on the striatal structures, which potentially could bias studies determining imaging outcome measures of interventions in HDGECs and probably also symptomatic HD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0252683","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T17:36:38Z","timestamp":1623432998000},"page":"e0252683","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hybrid 2-[18F] FDG PET\/MRI in premanifest Huntington\u2019s disease gene-expansion carriers: The significance of partial volume correction"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-1073","authenticated-orcid":true,"given":"Marie N. N.","family":"Hellem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tua","family":"Vinther-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Anderberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Budtz-J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Hjermind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke Andr\u00e9e","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,6,11]]},"reference":[{"key":"pone.0252683.ref001","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s disease: a clinical review.","volume":"5","author":"RA Roos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0252683.ref002","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.b.31232","article-title":"Indexing Disease Progression at Study Entry With Individuals At-Risk for Huntington Disease.","author":"Y Zhang","year":"2011"},{"issue":"1110","key":"pone.0252683.ref003","first-page":"204","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics.","volume":"10","author":"CA Ross","year":"2014","journal-title":"Nat Publ Gr."},{"issue":"3\u20134","key":"pone.0252683.ref004","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresbull.2010.04.003","article-title":"Striatal and white matter predictors of estimated diagnosis for Huntington disease","volume":"82","author":"JS Paulsen","year":"2010","journal-title":"Brain Res Bull"},{"issue":"3","key":"pone.0252683.ref005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neubiorev.2013.01.022","article-title":"Neuroscience and Biobehavioral Reviews Structural MRI in Huntington \u2018 s disease and recommendations for its potential use in clinical trials","volume":"37","author":"N Georgiou-karistianis","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"2","key":"pone.0252683.ref006","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease","volume":"47","author":"A Ciarmiello","year":"2006","journal-title":"J Nucl Med"},{"issue":"1","key":"pone.0252683.ref007","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JHD-120030","article-title":"Longitudinal Neuroimaging Biomarkers in Huntington\u2019s Disease.","volume":"2","author":"EM Rees","year":"2013","journal-title":"J Huntingtons Dis."},{"key":"pone.0252683.ref008","article-title":"Striatal molecular alterations in HD gene carriers: a systematic review and meta-analysis of PET studies","author":"F Niccolini","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"pone.0252683.ref009","article-title":"(18)F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size.","author":"A Ciarmiello","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"pone.0252683.ref010","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/brain\/awm217","article-title":"Thalamic metabolism and symptom onset in preclinical Huntington\u2019s disease","volume":"130","author":"a. Feigin","year":"2007","journal-title":"Brain"},{"issue":"5","key":"pone.0252683.ref011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410120504","article-title":"Cerebral metabolism and atrophy in Huntington\u2019s disease determined by 18FDG and computed tomographic scan","volume":"12","author":"DE Kuhl","year":"1982","journal-title":"Ann Neurol"},{"issue":"12","key":"pone.0252683.ref012","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00259-017-3775-4","article-title":"Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis","volume":"44","author":"MCF Cysouw","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"pone.0252683.ref013","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13023-014-0114-8","article-title":"A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington\u2019s disease.","volume":"9","author":"T Vinther-Jensen","year":"2014","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"pone.0252683.ref014","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2967\/jnumed.111.092726","article-title":"Performance Measurements of the Siemens mMR Integrated Whole-Body PET\/MR Scanner","volume":"52","author":"G Delso","year":"2011","journal-title":"J Nucl Med"},{"issue":"4","key":"pone.0252683.ref015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cpet.2016.05.003","article-title":"Clinical PET\/MR Imaging in Dementia and Neuro-Oncology.","volume":"11","author":"OM Henriksen","year":"2016","journal-title":"PET Clin"},{"key":"pone.0252683.ref016","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuroimage.2013.08.042","article-title":"Combined PET\/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone","volume":"84","author":"FL Andersen","year":"2014","journal-title":"Neuroimage"},{"issue":"2","key":"pone.0252683.ref017","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","article-title":"FreeSurfer.","volume":"62","author":"B Fischl","year":"2012","journal-title":"Neuroimage"},{"key":"pone.0252683.ref018","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","article-title":"Different partial volume correction methods lead to different conclusions: An18F-FDG-PET study of aging.","volume":"132","author":"DN Greve","year":"2016","journal-title":"Neuroimage"},{"issue":"21","key":"pone.0252683.ref019","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1088\/0031-9155\/57\/21\/7101","article-title":"Symmetric geometric transfer matrix partial volume correction for PET imaging: Principle, validation and robustness","volume":"57","author":"M Sattarivand","year":"2012","journal-title":"Phys Med Biol"},{"key":"pone.0252683.ref020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","article-title":"Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data","volume":"92","author":"DN Greve","year":"2014","journal-title":"Neuroimage"},{"key":"pone.0252683.ref021","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","article-title":"Different partial volume correction methods lead to different conclusions: An18F-FDG-PET study of aging.","volume":"132","author":"DN Greve","year":"2016","journal-title":"Neuroimage"},{"key":"pone.0252683.ref022","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.neuroimage.2014.09.034","article-title":"Accurate automatic estimation of total intracranial volume: A nuisance variable with less nuisance.","volume":"104","author":"IB Malone","year":"2015","journal-title":"Neuroimage"},{"key":"pone.0252683.ref023","first-page":"12","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"8","author":"N Turck","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"pone.0252683.ref024","author":"KJ Friston","year":"2006","journal-title":"Statistical Parametric Mapping: The Analysis of Functional Brain Images"},{"issue":"3","key":"pone.0252683.ref025","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8","article-title":"Automated Talairach Atlas Labels For Functional Brain Mapping.","volume":"10","author":"L JL","year":"2000","journal-title":"Hum Brain Mapp"},{"issue":"4 PART II","key":"pone.0252683.ref026","article-title":"The Talairach Daemon a database server for talairach atlas labels.","volume":"5","author":"JL L","year":"1997","journal-title":"Neuroimage"},{"issue":"2","key":"pone.0252683.ref027","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1750-3639.2012.00629.x","article-title":"Degeneration of the cerebellum in huntingtons disease (HD): Possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process.","volume":"23","author":"U R\u00fcb","year":"2013","journal-title":"Brain Pathol"},{"issue":"7","key":"pone.0252683.ref028","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.36.7.888","article-title":"Positron emission tomography in the early diagnosis of Huntington\u2019s disease","volume":"36","author":"MR Hayden","year":"1986","journal-title":"Neurology"},{"issue":"6","key":"pone.0252683.ref029","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00259-016-3324-6","article-title":"Current status of PET imaging in Huntington\u2019s disease","volume":"43","author":"G Pagano","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"pone.0252683.ref030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington\u2019s disease in the TRACK-HD study: Analysis of 24 month observational data","volume":"11","author":"SJ Tabrizi","year":"2012","journal-title":"Lancet Neurol"},{"issue":"6","key":"pone.0252683.ref031","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","article-title":"Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease.","volume":"65","author":"JCH Van Oostrom","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"pone.0252683.ref032","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/JHD-189003","article-title":"Huntington\u2019s Disease Clinical Trials Corner: August 2018.","volume":"7","author":"FB Rodrigues","year":"2018","journal-title":"J Huntingtons Dis."},{"issue":"6","key":"pone.0252683.ref033","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00259-012-2114-z","article-title":"18F-FDG PET uptake in the pre-Huntington disease caudate affects the time-to-onset independently of CAG expansion size","volume":"39","author":"A Ciarmiello","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T17:37:17Z","timestamp":1623433037000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252683"}},"subtitle":[],"editor":[{"given":"Pedro","family":"Fernandez-Funez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,6,11]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252683","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,11]]}}}